QGEN
Qiagen NV
Price:  
48.34 
USD
Volume:  
770,537.00
Netherlands | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

QGEN EV/EBITDA

-26.2%
Upside

As of 2025-07-04, the EV/EBITDA ratio of Qiagen NV (QGEN) is 16.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. QGEN's latest enterprise value is 11,196.50 mil USD. QGEN's TTM EBITDA according to its financial statements is 699.29 mil USD. Dividing these 2 quantities gives us the above QGEN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 13.5x - 17.3x 15.2x
Forward P/E multiples 18.8x - 20.3x 19.6x
Fair Price 24.35 - 52.44 35.69
Upside -49.6% - 8.5% -26.2%
48.34 USD
Stock Price
35.69 USD
Fair Price

QGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-03 16.01
2025-07-02 16.10
2025-07-01 15.97
2025-06-30 15.92
2025-06-27 15.83
2025-06-26 15.92
2025-06-25 15.74
2025-06-24 15.67
2025-06-23 15.51
2025-06-20 15.52
2025-06-18 15.46
2025-06-17 15.46
2025-06-16 15.74
2025-06-13 15.63
2025-06-12 15.72
2025-06-11 15.51
2025-06-10 15.35
2025-06-09 15.34
2025-06-06 15.13
2025-06-05 15.15
2025-06-04 15.20
2025-06-03 15.06
2025-06-02 14.95
2025-05-30 15.02
2025-05-29 14.98
2025-05-28 14.78
2025-05-27 14.62
2025-05-23 14.06
2025-05-22 14.15
2025-05-21 14.15
2025-05-20 14.26
2025-05-19 14.30
2025-05-16 14.25
2025-05-15 14.12
2025-05-14 13.78
2025-05-13 14.08
2025-05-12 14.35
2025-05-09 14.00
2025-05-08 14.10
2025-05-07 14.24
2025-05-06 14.10
2025-05-05 14.30
2025-05-02 14.40
2025-05-01 14.11
2025-04-30 14.28
2025-04-29 14.24
2025-04-28 14.19
2025-04-25 14.07
2025-04-24 14.38
2025-04-23 14.15